Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy

by mm-red | Jul 29, 2020

Background: Data from the 3 omalizumab pivotal trials inpatients with chronic idiopathic urticaria/chronic spontaneous urticaria (CIU/CSU) represent the largest database of patients reported to date with refractory disease (omalizumab, n[733;placebo, n[242)....

A review of international recommendations for the diagnosis and management of chronic urticaria

by mm-red | Jun 23, 2020

Both spontaneous and inducible forms of chronic ur- ticaria pose a significant economic burden and have an adverse effect on patients’ quality of life. The in- ternational guidelines and US practice parameters for the diagnosis and management of chronic urtica- ria...

Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency

by mm-red | Jun 12, 2020

This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Devel- opment and Evaluation (GRADE) working group. The conference was held on 1 December 2016. It is a joint...

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

by mm-red | Jun 9, 2020

This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Devel- opment and Evaluation (GRADE) working group. The conference was held on 1 December 2016. It is a joint...

Methods report on the development of the 2013 revision and update of the EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria

by mm-red | Jun 6, 2020

This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the ‘Grading of Recommenda- tions Assessment, Development and Evaluation’ (GRADE) methodology and a structured consensus conference...